Irene Litvan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Irene Litvan | Clinical Neuroscience | Best Researcher Award

Dr. Irene Litvan | University of California San Diego | United States

Dr. Irene Litvan, MD, is the Tasch Endowed Professor of Neurology and Director of the Parkinson and Other Movement Disorders Center at the University of California, San Diego. She is internationally recognized for her pioneering work in movement disorders, particularly Parkinson’s disease and related neurodegenerative conditions. As a leading clinician-scientist, she has directed major multicenter and international initiatives to develop clinical and neuropathologic diagnostic criteria, identify disease biomarkers, and advance therapeutic interventions. Her extensive research spans epidemiologic, genetic, and clinico-pathologic correlation studies that have significantly deepened the understanding of movement disorders. Dr. Litvan’s scholarly impact is reflected in 6 published documents, 10 citations, and an h-index of 1. Throughout her distinguished career, she has received consistent funding support from national and international agencies, industry collaborations, and philanthropic organizations. Beyond her research, she has served as a dedicated mentor, shaping the next generation of neurologists and neuroscientists. Dr. Litvan also leads the UC San Diego Parkinson and Other Movement Disorders Center, fostering clinical excellence and research innovation aimed at improving diagnosis, management, and quality of life for individuals with Parkinson’s disease and other movement-related neurological disorders.

Featured Publications

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., et al. (2015). MDS clinical diagnostic criteria for Parkinson’s disease. Movement Disorders, 30(12), 1591–1601.

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., et al. (2005). Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology, 65(12), 1863–1872.

Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A frontal assessment battery at bedside. Neurology, 55(11), 1621–1626.

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., et al. (2007). Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders, 22(12), 1689–1707.

Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., et al. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27(3), 349–356.

Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., et al. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS–SPSP international workshop. Neurology, 47(1), 1–9.

Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., et al. (2017). Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria. Movement Disorders, 32(6), 853–864.

Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mrs. Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Mrs. Claudia Pauciulo | Borghesiana Veterinary Clinic | Italy

Mrs. Claudia Pauciulo is the Head of the Neurology and Neurosurgery Department at Borghesiana Veterinary Clinic in Rome, Italy, and a certified veterinary neurologist completing her ECVN Residency. She holds a Master’s Degree in Diagnostic Imaging and a GP Certificate in Neurology, combining strong academic training with extensive clinical experience in advanced diagnostics (MRI, CT), neurosurgery, and case management. Her research focuses on feline and canine hyperesthesia syndromes, central nervous system lymphoma, intervertebral disc disease, and peripheral neuropathies. Dr. Pauciulo has published as both first author and coauthor in high-impact, peer-reviewed journals, including the Journal of Veterinary Internal Medicine, Journal of the American Veterinary Medical Association, Veterinary Record Case Reports, Journal of Small Animal Practice, and Veterinary Sciences (MDPI). She maintains an active citation record with growing visibility in Scopus- and SCI-indexed publications. Her current h-index is 2, with a total of 10 citations across multiple publications. Through her collaborative research with leading ECVN diplomates and contributions to international neurology congresses, Dr. Pauciulo continues to advance veterinary neuroscience, integrating clinical excellence with innovative research to improve evidence-based therapeutic strategies for neurological disorders in companion animals.

Profiles: Orcid | Linked In

Featured Publication

Pauciulo, C., & Gallucci, A. (2025, September 25). Long‐term outcome of presumptive idiopathic hyperesthesia syndrome in a dog treated with fluoxetine. Veterinary Record Case Reports.

Jaleel Miyan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Jaleel Miyan | Clinical Neuroscience | Best Researcher Award

Dr. Jaleel Miyan | The University of Manchester | United Kingdom

Dr. Jaleel Ahmad Miyan is a distinguished British neuroscientist and Senior Lecturer at the Faculty of Biology, Medicine & Health, Division of Neuroscience, University of Manchester, with a long-standing career dedicated to understanding cerebrospinal fluid (CSF) physiology and its role in neurological disorders. As President of the Society for Research into Hydrocephalus & Spina Bifida and a Fellow of both the Higher Education Academy and the Royal Society of Biology, he is recognized internationally for his expertise in cerebral folate metabolism and hydrocephalus research. His principal work focuses on fetal-onset and neonatal hydrocephalus, aiming to develop a non-invasive, non-surgical treatment to address global disparities in care. Miyan has supervised numerous PhD and Masters students, postdoctoral researchers, and technicians, fostering research excellence. He has published over 120 peer-reviewed research papers and reviews, with an h-index of 34, and his work has garnered substantial citations, reflecting his impact in neuroscience. He has served on editorial boards, contributed to major research projects, and secured significant funding for studies on folate metabolism in neurological conditions. Miyan’s scholarship is accessible through his ResearchGate, Orcid, and Google Scholar profiles, showcasing his profound contributions to advancing neuroscience and improving treatments for devastating neurological conditions.

Profiles : Google Scholar | Orcid | Research Gate

Featured Publications

Downing, J. E. G., & Miyan, J. A. (2000). Neural immunoregulation: Emerging roles for nerves in immune homeostasis and disease. Immunology Today, 21(6), 281–289.

Assas, B. M., Pennock, J. I., & Miyan, J. A. (2014). Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis. Frontiers in Neuroscience, 8, 23.

Miyan, J. A., Nabiyouni, M., & Zendah, M. (2003). Development of the brain: A vital role for cerebrospinal fluid. Canadian Journal of Physiology and Pharmacology, 81(4), 317–328.

Gazi, E., Dwyer, J., Lockyer, N. P., Miyan, J., Gardner, P., Hart, C., & Brown, M., et al. (2005). Fixation protocols for subcellular imaging by synchrotron‐based Fourier transform infrared microspectroscopy. Biopolymers: Original Research on Biomolecules, 77(1), 18–30.

Mashayekhi, F., Draper, C. E., Bannister, C. M., Pourghasem, M., & Miyan, J. A., et al. (2002). Deficient cortical development in the hydrocephalic Texas (H‐Tx) rat: A role for CSF. Brain, 125(8), 1859–1874.

Owen‐Lynch, P. J., Draper, C. E., Mashayekhi, F., Bannister, C. M., & Miyan, J. A. (2003). Defective cell cycle control underlies abnormal cortical development in the hydrocephalic Texas rat. Brain, 126(3), 623–631.

Junliang Yuan | Clinical Neuroscience | Neuroscience Future Leader Award

Published on by Neuroscientists

Prof. Dr. Junliang Yuan | Clinical Neuroscience | Neuroscience Future Leader Award

Prof. Dr. Junliang Yuan | Peking University Sixth Hospital | China

Dr. Junliang Yuan is a neurologist, Associate Professor, and Director of the Department of Neurology at Peking University Sixth Hospital, Beijing, China. He earned his Bachelor’s degree in Clinical Medicine from Jining Medical College, a Master’s in Neurology from Dalian Medical University, and a Medical Degree in Neurology from Capital Medical University, followed by a postdoctoral fellowship at McLean Hospital/Harvard Medical School. He has also served as Associate Professor of Neurology at Beijing Chaoyang Hospital. Dr. Yuan’s research focuses on neuropsychiatric disorders, neurodegenerative diseases, cognition and dementia, movement disorders including Parkinson’s disease, and sleep disorders. He has secured multiple prestigious research grants, including funding from the Science and Technology Innovation 2030 “Brain Science and Brain-like Research” major project, the National Natural Science Foundation of China, the Chinese Academy of Sciences, and several Beijing Municipal health research programs. His scholarly output includes 91 published documents, which have been cited 1,585 times by 1,508 other publications, reflecting his influence in the field with an h-index of 22. Through his leadership and research, Dr. Yuan continues to contribute significantly to advancing clinical and translational neuroscience, with a strong focus on improving the diagnosis, management, and treatment of neurological disorders.

Profiles: Scopus | Google Scholar | Research Gate | Linked In | Staff Page

Featured Publications

Li, Y., Li, M., Zhang, X., Shi, Q., Yang, S., Fan, H., Qin, W., Yang, L., Yuan, J., Jiang, T., … (2017). Higher blood–brain barrier permeability is associated with higher white matter hyperintensities burden. Journal of Neurology, 264(7), 1474–1481.

Yuan, J., Yang, S., Wang, S., Qin, W., Yang, L., & Hu, W. (2017). Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults: A case report and literature review. BMC Neurology, 17(1), 103.

Li, Y., Li, M., Yang, L., Qin, W., Yang, S., Yuan, J., Jiang, T., & Hu, W. (2019). The relationship between blood–brain barrier permeability and enlarged perivascular spaces: A cross-sectional study. Clinical Interventions in Aging, 14, 871–878.

Chen, Y., Zhang, J., Wang, Y., Yuan, J., & Hu, W. (2016). Efficacy of cholinesterase inhibitors in vascular dementia: An updated meta-analysis. European Neurology, 75(3–4), 132–141.

Li, X., Yuan, J., Liu, L., & Hu, W. (2019). Antibody-LGI1 autoimmune encephalitis manifesting as rapidly progressive dementia and hyponatremia: A case report and literature review. BMC Neurology, 19(1), 19.

Zhang, X., Ding, L., Yang, L., Qin, W., Yuan, J., Li, S., & Hu, W. (2016). Brain atrophy correlates with severe enlarged perivascular spaces in basal ganglia among lacunar stroke patients. PLoS ONE, 11(2), e0149593.

Li, X., Yuan, J., Yang, L., Qin, W., Yang, S., Li, Y., Fan, H., & Hu, W. (2017). The significant effects of cerebral microbleeds on cognitive dysfunction: An updated meta-analysis. PLoS ONE, 12(9), e0185145.

Rezvan Ghafarzadegan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mrs. Rezvan Ghafarzadegan | Clinical Neuroscience | Best Researcher Award

Mrs. Rezvan Ghafarzadegan | Tarbiat Modares University | Iran

Rezvan Ghafarzadegan is a distinguished nursing scholar specializing in Medical-Surgical Education, holding an M.Sc. in Nursing from Tehran University of Medical Sciences and a B.Sc. in Nursing from Arak University of Medical Sciences, both completed with exceptional academic honors and outstanding GPAs. She is currently a Ph.D. candidate in Nursing at Tarbiat Modares University, demonstrating a strong commitment to advancing nursing education and clinical practice. Rezvan has extensive teaching experience, serving as an instructor for Medical-Surgical Nursing, Emergency Medicine, Internal Diseases, Medical Ethics, Pathophysiology, Orthopedic Surgical Technology, and Introduction to Surgical Technology. She also has broad clinical instruction expertise in Emergency, Internal Medicine (Gastroenterology & Endocrinology), Orthopedics, Neurosurgery, and General Surgery, along with operating room education. Her scholarly contributions include 9 published documents that have collectively earned 31 citations, reflecting her growing impact in the field, and she holds an h-index of 3. Recognized throughout her academic journey as an exceptional talent student, Rezvan combines clinical expertise with a deep dedication to research, striving to improve nursing education and patient care through both her teaching and scientific endeavors.

Profiles: Scopus | Orcid | Research gate

Featured Publications

Zarei, M., Norouzi, N., Teymoori, E., & Ghafarzadegan, R. (2025). Covering sterile instrument tables to prevent airborne bacterial contamination and surgical wound infections: A narrative review of operating room nursing practices. Perioperative Care and Operating Room Management, 100495.

Ghafarzadegan, R., Zarei, M., Norouzi, N., Mirbagher Ajorpaz, N., Lotfi, S. M., Rasooli Manesh, S. M., Akbari, H., & Abedi, A. (2025). Efficacy of an Iranian herbal medicine formula for postoperative constipation in trauma patients with hip and lower limb fractures: A triple-blind, placebo-controlled randomized clinical trial. International Journal of Orthopaedic and Trauma Nursing, 101163.

Javaheri, J., Asgari, M., & Ghafarzadegan, R. (2023). The effect of Nigella sativa powder on blood sugar and lipid profiles in type 2 diabetic patients. Jundishapur Journal of Natural Pharmaceutical Products, e135757.

Gang Cao | Behavioral Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Gang Cao | Behavioral Neuroscience | Best Researcher Award

Anhui University of Finance and Economics | China

Gang Cao (Ph.D.) is a Lecturer at the International Business School, Anhui University of Finance and Economics, with academic training in Business Administration and Management Science and Engineering from Shanghai University and Anhui University of Finance and Economics. His research focuses on AI capabilities, entrepreneurship, and innovation, and he has published in leading international journals such as the Journal of Business Research, Management and Organization Review, R&D Management, Plos One, and the International Journal of Conflict Management, as well as in top Chinese journals including Journal of Management Sciences in China and Journal of Economic Management. He has authored and co-authored multiple high-impact studies addressing themes such as entrepreneurial well-being, entrepreneurial failure and reentry, bricolage and disruptive innovation, digital identity change, impression management, and the integration of artificial intelligence with entrepreneurship and business model innovation. His work combines quantitative, qualitative, and computational methodologies, offering both theoretical contributions and practical insights into entrepreneurial behavior and firm evolution. Gang Cao has achieved an h-index of 5, with 11 documents and 102 citations, reflecting his growing academic impact and recognition in the fields of entrepreneurship, innovation management, and digital transformation. Through his interdisciplinary and collaborative research, he continues to advance understanding of the complex dynamics driving entrepreneurial success and organizational performance.

Profiles: Google Scholar

Featured Publications

“Exploring the relationship between entrepreneurial failure and conflict between work and family from the conservation of resources perspective.”

“Entrepreneurial Bricolage and Disruptive Innovation: The Joint Effect of Learning From Failure and Institutional voids.”

“Striking the balance: Configurations of causation and effectuation principles for SME performance.”

Stanley Zimba | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Stanley Zimba | Clinical Neuroscience | Best Researcher Award

Dr. Stanley Zimba | University of Zambia School of Medicine | Zambia

Stanley Zimba is a distinguished neurologist and academic whose career reflects a rare blend of clinical excellence, research innovation, and medical leadership. With a strong educational foundation in medicine and advanced training in neurology, he has dedicated himself to improving neurological care and education in Zambia. His professional endeavors span across clinical practice in leading hospitals, teaching roles at multiple universities, and leadership in professional organizations. His research has focused on neuroHIV, neuromuscular disorders, and epilepsy, often conducted in collaboration with globally recognized institutions. His outstanding work has earned him prestigious international fellowships, awards, and recognition, making him a prominent voice in neurology within sub-Saharan Africa.

Profile

Orcid

Early Academic Pursuits

Stanley Zimba began his academic journey with a strong foundation in the sciences, excelling early in his studies and securing recognition as one of the most outstanding students of his time. His pursuit of higher education led him to the University of Zambia, where he undertook rigorous training in medicine. He first completed a degree in Human Biology before advancing to obtain his Bachelor of Medicine and Bachelor of Surgery. His intellectual curiosity and commitment to medical excellence propelled him to further specialization with a Master of Medicine in Internal Medicine. Driven by a passion for advancing neurological sciences, he embarked on advanced fellowship training in Adult Neurology and later pursued doctoral research in Adult Neurology at the University of Zambia, building the foundation for his career as a clinician–scientist.

Professional Endeavors

Zimba’s professional career has been deeply rooted in both clinical practice and academic medicine. As a consultant neurologist, he has played a central role in establishing neurology services within Zambia’s leading medical institutions, including the University Teaching Hospital where he leads the Neurology and Hematology Unit. His expertise has been sought by private hospitals, where he contributes to expanding access to specialized neurological care. Beyond hospital practice, his influence extends into academia, where he serves as an honorary lecturer across several medical universities in Zambia, shaping the next generation of physicians. His leadership extends further into professional organizations, where he has assumed prominent roles that guide the direction of neurological practice and training within the country.

Contributions and Research Focus

At the heart of Zimba’s career lies a dedication to advancing knowledge in neurology, with particular attention to neurological complications of infectious diseases, neuroHIV, neuromuscular disorders, and epilepsy. His research activities have been strengthened through international collaborations with institutions such as Johns Hopkins University, Harvard University, and the University of Cape Town. He has engaged in translational research exploring the interface between infectious diseases and neurological health, addressing critical gaps in understanding how conditions such as HIV contribute to neurological morbidity. His academic work reflects a blend of clinical expertise and research innovation, positioning him as a leading figure in developing evidence-based approaches to neurological care in sub-Saharan Africa.

Accolades and Recognition

Zimba’s academic and professional journey has been marked by significant recognition from both local and international institutions. He has received prestigious scholarships and fellowships from globally renowned organizations, including the American Academy of Neurology, the Fogarty International Center, and the Peripheral Nerve Society. His contributions have also been acknowledged through competitive awards for scholarly excellence, such as recognition for best scientific presentations and leadership fellowships in global health research. These honors reflect not only his personal commitment to academic excellence but also the international value of his work in neurology.

Impact and Influence

Through his roles in clinical practice, teaching, and leadership, Zimba has had a profound impact on the development of neurology in Zambia. As head of neurology services in the nation’s largest teaching hospital, he has shaped clinical protocols and advanced the training of physicians in specialized neurological care. His academic mentorship has inspired many young medical professionals to pursue careers in neurology and internal medicine. His leadership in professional associations has also created platforms for collaboration, advocacy, and policy development, ensuring that neurological health remains a priority in national and regional health agendas.

Legacy in Medical Leadership

Zimba’s leadership extends beyond the clinic and classroom into national medical governance. By directing specialist training programs and contributing to the regulation of internal medicine through the Health Professions Council of Zambia, he has influenced the standards of medical education and practice across the country. His presidency of the Neurological Association of Zambia positions him as a central figure in shaping the future of neurological practice, advocacy, and awareness, ensuring that patients with neurological disorders receive improved recognition and care.

Future Contributions

Looking forward, Zimba is poised to leave a lasting legacy through his continued commitment to advancing neurological sciences in Zambia and the wider region. His doctoral research and international collaborations promise to generate new insights into neurological disease management, while his leadership roles will likely foster stronger systems for specialist training and healthcare delivery. By combining clinical expertise, academic mentorship, and institutional leadership, he is set to play an instrumental role in positioning Zambia as a center of excellence for neurology in Africa. His career trajectory illustrates a deep dedication not only to scientific advancement but also to the betterment of patient care and health systems in resource-limited settings.

Publications

The Association of Premature Atherosclerosis with Ischemic Stroke in Young People with HIV in Lusaka, Zambia
Authors: Stanley Zimba; Owen Ngalamika; Emmanuel Mukambo; Theresa Shankanga; Bwalya Mulenga; Mike Chisha; Violet Kayamba; Lloyd Mulenga; Omar Siddiqi; Owen A. Ross et al.
Year: 2025

Clinical Reasoning: Rapidly Progressive Dementia in a Man With HIV Infection and Undetectable Plasma Viral Load
Authors: Lorraine Chishimba Chishimba; Mashina Chomba; Stanley Zimba; Melody Tunsubilege Asukile; Obrie Makai; Deanna R. Saylor
Year: 2023

The case of a 42‐year‐old man with progressive gait instability, dysarthria, and dysphagia
Authors: Jennifer Adrissi; Mashina Chomba; Lorraine Chishimba; Stanley Zimba; Igor J. Koralnik; Deanna Saylor
Year: 2023

A Notable Prevalence of HIV-Associated Stroke in an Endemic Region
Authors: Stanley Zimba; Laura Benjamin
Year: 2022

Implementation of a Teleneurology Clinic in Zambia during the COVID‐19 Pandemic
Authors: Melody Asukile; Lorraine Chishimba; Mashina Chomba; Moses Mataa; Frighton Mutete; Naluca Mwendaweli; Kunda Yumbe; Stanley Zimba; Gloria Habanyama; Sydney Shampile et al.
Year: 2022

Inpatient Management of Acute Stroke of Unknown Type in Resource-Limited Settings
Authors: Morgan L. Prust; Deanna Saylor; Stanley Zimba; Fred Stephen Sarfo; Gentle S. Shrestha; Aaron Berkowitz; Nirali Vora
Year: 2022

Clinical Reasoning: An Unusual Case of Acute Psychosis and Tetraparesis in a Young Zambian Man
Authors: Stanley Zimba; Lorraine Chishimba; Mashina Chomba; Deanna Saylor
Year: 2021

Immune reconstitution inflammatory syndrome: a report of TB-IRIS after switching from efavirenz to dolutegravir
Authors: Stanley Zimba; Nyuma Mbewe; Lorraine Chishimba; Mashina Chomba; Deanna Saylor
Year: 2021

Conclusion

Dr. Zimba’s contributions exemplify the qualities of a transformative clinician–scientist who bridges research, practice, and leadership. His work has significantly advanced the understanding and treatment of neurological disorders in Zambia, while also elevating medical education and training standards. Through his leadership positions, he has shaped healthcare policy, specialist training, and advocacy for neurological health. Looking to the future, his research and leadership promise to strengthen neurology as a field in Africa, leaving a legacy of scientific advancement, patient-centered care, and mentorship for future generations.

Reza Amani | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Reza Amani | Clinical Neuroscience | Best Researcher Award

Prof. Reza Amani | Isfahan University of Medical Sciences | Iran

Dr. Reza Amani is a distinguished academic and clinical nutritionist whose career has been dedicated to advancing the science of human nutrition and dietetics. His early academic training in nutrition science laid a solid foundation for his extensive research and clinical work in chronic disease management, functional foods, and weight management therapies. He has held key academic and leadership positions, contributed prolifically to scholarly literature, and engaged in international teaching and research collaborations. His expertise has also been recognized through fellowships, visiting professorships, and advisory roles in national health and food policy.

Profile

Google Scholar

Early Academic Pursuits

Dr. Reza Amani began his academic journey in the field of nutrition science with a deep commitment to understanding the relationship between diet and health. His early studies in nutrition provided a strong scientific foundation, which he further expanded through advanced degrees in nutrition science. His doctoral research refined his expertise in applied human nutrition and clinical dietetics, laying the groundwork for his future contributions to both academia and clinical practice. These formative years were crucial in shaping his lifelong dedication to advancing knowledge in clinical nutrition and diet therapy.

Professional Endeavors

Over the course of his career, Dr. Amani has held influential academic and leadership positions in leading medical universities, where he has contributed to teaching, mentoring, and program development. His professional endeavors extend beyond academia, with significant roles in nutrition consultation, policy advising, and collaboration with the food industry. Through his service as a head of departments and research centers, he has demonstrated effective leadership in advancing institutional goals while nurturing an environment of academic excellence.

Contributions and Research Focus

Dr. Amani’s scholarly contributions center on clinical nutrition, dietetics, and the therapeutic applications of functional foods. His research has particularly emphasized medical nutrition therapy in chronic diseases, antioxidant-rich diets, and weight management approaches. Through a combination of clinical practice and research, he has explored innovative nutritional solutions and therapeutic diets that address modern health challenges. His body of work reflects a dedication to bridging science and practice, ensuring that research findings translate into effective interventions for public health and patient care.

Academic Publications and Knowledge Dissemination

A prolific scholar, Dr. Amani has authored an extensive collection of scientific papers and academic books in the field of nutrition and dietetics. His publications have enriched the scientific community with insights into functional food formulations, nutritional interventions for chronic disease management, and applied strategies in weight reduction. Beyond publishing, he has actively engaged in organizing and managing academic workshops, seminars, and webinars, ensuring the dissemination of cutting-edge knowledge to a wider audience of professionals, students, and practitioners.

Accolades and Recognition

Dr. Amani’s expertise and commitment have been recognized both nationally and internationally. He has been invited as a visiting scholar and professor at esteemed universities abroad, reflecting his international standing in the field of nutrition science. His fellowship training in clinical nutrition, with a particular focus on obesity management, further underscores his professional recognition and global engagement. His long-term membership in national boards and advisory positions within health ministries and industry demonstrates the trust placed in his expertise at the highest levels of nutrition governance.

Impact and Influence

The impact of Dr. Amani’s work extends across multiple domains, from shaping academic curricula and research priorities to influencing national nutrition policies and guiding food industries. His consultancy roles with health sectors and large industries highlight his ability to apply academic insights to real-world contexts. Moreover, his clinical nutrition practice and ownership of diet therapy clinics serve as a model of integrating academic knowledge with direct patient care. By advancing both scientific knowledge and practical solutions, he has influenced a generation of students, colleagues, and policymakers.

Legacy and Future Contributions

Dr. Amani’s legacy lies in his sustained contributions to clinical nutrition research, his leadership in academic institutions, and his role in shaping health strategies through nutritional science. As a mentor, author, and consultant, he has created pathways for future advancements in functional food research and chronic disease management. Looking forward, his future contributions are expected to continue bridging global collaborations, fostering innovative dietary solutions, and training the next generation of nutrition scientists who will carry forward his vision of integrating scientific research with human health advancement.

Publications

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … – M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, … – 2024

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … – M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, … – 2024

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 – JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, … – 2024

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 – SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, … – 2024

Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 – VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, … – 2024

Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial – N Sharifi, R Amani, E Hajiani, B Cheraghian – 2014

Shiftworking, nutrition and obesity: implications for workforce health-a systematic review – R Amani, T Gill – 2013

Inflammatory cytokines and oxidative stress biomarkers in irritable bowel syndrome: association with digestive symptoms and quality of life – R Choghakhori, A Abbasnezhad, A Hasanvand, R Amani – 2017

Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global … – RG Bender, SB Sirota, LR Swetschinski, RMV Dominguez, A Novotney, … – 2024

Correlation between dietary zinc intakes and its serum levels with depression scales in young female students – R Amani, S Saeidi, Z Nazari, S Nematpour – 2010

Conclusion

Dr. Amani’s career reflects a remarkable combination of academic scholarship, clinical expertise, and leadership in nutrition science. His contributions have not only advanced research in functional foods and medical nutrition therapy but have also translated into practical health solutions for chronic disease management and weight control. With a legacy of over a hundred publications, leadership in research centers, and consultancy roles at the national level, he stands as a leading figure in the field. Moving forward, his work is set to inspire new generations of nutrition scientists and further strengthen global collaborations in advancing human health through nutrition.

Gulcin Gacar | Neurodegenerative Disease | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Gulcin Gacar | Neurodegenerative Disease | Best Researcher Award

Prof. Dr. Gulcin Gacar | Kocaeli University | Turkey

Associate Professor Dr. Gulcin Gacar of Kocaeli University is a distinguished researcher and educator in the fields of stem cell biology, regenerative medicine, and clinical microbiology. With over 200 scientific publications, including 54 in Web of Science and 37 in Scopus, she has garnered more than 900 citations and achieved an h-index of 17. Her groundbreaking research focuses on mesenchymal stem cells and exosomes, particularly their applications in neurodegenerative diseases like Alzheimer’s. She leads nationally funded projects and serves as a mentor to graduate students, contributing significantly to Turkey’s scientific advancement in cellular and molecular therapy.

Academic Profile

Google Scholar
Orcid

Early Academic Pursuits

From the outset of her academic journey, Dr. Gülçin Gacar exhibited a strong dedication to medical sciences, particularly clinical microbiology and regenerative medicine. Her foundational studies laid the groundwork for her specialization in stem cell biology and advanced biomedical techniques. As she advanced through the academic ranks, her commitment to translational research became evident, inspiring a deep dive into the dynamic world of mesenchymal stem cells and cellular therapies.

Professional Endeavors

Currently serving as an Associate Professor at Kocaeli University, Dr. Gacar is affiliated with the Center for Stem Cell and Gene Therapies under the Institute of Health Sciences. She plays a critical role in bridging theoretical knowledge with clinical application. Her professional journey is characterized by a robust combination of teaching, research, and leadership, where she supervises graduate-level research and oversees important institutional initiatives in stem cell-based innovation.

Contributions and Research Focus

Dr. Gacar’s research primarily revolves around mesenchymal stem cells, exosomes (extracellular vesicles), and advanced applications of stem cell biology. One of her key projects involves investigating the therapeutic potential of exosomes derived from adipose tissue-origin mesenchymal stem cells on Alzheimer’s disease models using human neuroblastoma SHSY5Y cells. This cutting-edge study, supported by national scientific funding, illustrates her focus on neurological disorders and cellular therapies. With over 200 academic publications, including 54 indexed in Web of Science and 37 in Scopus, her work has become a cornerstone in regenerative medicine and neurocellular research.

Accolades and Recognition

Dr. Gacar’s exceptional scholarship is reflected in her impressive citation record—garnering over 900 citations with an h-index of 16 on Web of Science and 17 on Scopus. These metrics not only underscore the academic relevance of her research but also highlight her influence in the global scientific community. Her contributions have positioned her as a key opinion leader and trusted consultant in TÜBİTAK-funded national projects, further validating her expertise and dedication to scientific excellence.

Impact and Influence

Beyond publications and projects, Dr. Gacar is actively involved in mentoring the next generation of scientists. She has supervised numerous graduate theses, fostering a research culture grounded in innovation, rigor, and ethical science. Her influence extends into policy-making and practical clinical research, making her a vital figure in the implementation of stem cell technologies in both experimental and therapeutic contexts.

Legacy and Future Contributions

Dr. Gacar continues to expand the frontiers of stem cell research and regenerative neuroscience. Her ongoing efforts in developing novel diagnostic and therapeutic modalities through cellular and molecular engineering are poised to transform clinical approaches to degenerative diseases. With each project and publication, she reinforces her commitment to scientific discovery and paves the way for future breakthroughs in biotechnology and personalized medicine.

Neuroscience and Regenerative Innovation

At the intersection of neuroscience and regenerative biology, Dr. Gacar’s work exemplifies the possibilities of interdisciplinary research. Her current focus on exosome-based therapies in neurodegenerative conditions represents a bold step into the future of non-invasive, cell-free therapeutics. As the landscape of neuroscience evolves, her pioneering work will undoubtedly contribute to novel clinical strategies and global scientific advancement.

Publication

Isolation and in vitro characterisation of dental pulp stem cells from natal teeth
E Karaöz, BN Doğan, A Aksoy, G Gacar, S Akyüz, S Ayhan, ZS Genç
2010

Characterization of mesenchymal stem cells from rat bone marrow: ultrastructural properties, differentiation potential and immunophenotypic markers
E Karaoz, A Aksoy, S Ayhan, AE Sarıboyacı, F Kaymaz, M Kasap
2009

Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum
K Schallmoser, E Rohde, A Reinisch, C Bartmann, D Thaler, C Drexler, …
2008

High prevalence of OXA-51-type class D β-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple …
H Vahaboglu, F Budak, M Kasap, G Gacar, S Torol, A Karadenizli, …
2006

Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems
PC Demircan, AE Sariboyaci, ZS Unal, G Gacar, C Subasi, E Karaoz
2011

Protective effects of resveratrol on aging-induced cognitive impairment in rats
SS Gocmez, N Gacar, T Utkan, G Gacar, PJ Scarpace, N Tumer
2016

The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets
AT Özdemir, RBÖ Özdemir, C Kırmaz, AE Sarıboyacı, ZSÜ Halbutoğlları, …
2016

PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp.
F Kolayli, G Gacar, A Karadenizli, A Sanic, H Vahaboglu, Study Group
2005

Phenotypic and proteomic characteristics of human dental pulp derived mesenchymal stem cells from a natal, an exfoliated deciduous, and an impacted third molar tooth
G Akpinar, M Kasap, A Aksoy, G Duruksu, G Gacar, E Karaoz
2014

The role of PIN1 on odontogenic and adipogenic differentiation in human dental pulp stem cells
YM Lee, SY Shin, SS Jue, IK Kwon, EH Cho, ES Cho, SH Park, EC Kim
2014

Conclusion 

Considering her scholarly output, impactful research on stem cell-based therapies, leadership in national research initiatives, and dedication to mentoring, Dr. Gulcin Gacar is highly deserving of the Best Researcher Award. Her innovative work in exosome-based treatment strategies for neurodegenerative diseases positions her as a leader in translational medical science. With continued emphasis on global engagement and high-impact dissemination, her research will not only advance scientific frontiers but also contribute meaningfully to patient care and public health. Thus, she stands as an exemplary model of academic excellence, innovation, and social relevance in biomedical sciences.

Antonella Santuccione Chadha | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Antonella Santuccione Chadha | Clinical Neuroscience | Best Researcher Award

Dr. Antonella Santuccione Chadha, Women` s Brain Foundation,  Switzerland.

Dr. Antonella Chadha Santuccione is a highly accomplished clinical pathologist, neuroscientist, and executive leader with notable expertise in clinical trial management and cognitive behavioral therapy. Born in Italy and based in Switzerland, she has held executive roles and board memberships across biotech and healthcare organizations. She is also the founder and pro-bono CEO of the Women’s Brain Foundation, emphasizing her commitment to neuroscience and gender-specific brain health.

Profile

Scopus
Orcid

📚 Early Academic Pursuits

Dr. Antonella Chadha Santuccione’s academic foundation is deeply rooted in medical science and behavioral therapy, reflecting her passion for understanding the human mind and body. Born on June 13, 1974, in Penne, Italy, she pursued her education in medicine, earning her MD with specialization in Clinical Pathology. Furthering her academic rigor, she attained credentials from FMH and MEBEKO and completed a CAS in Clinical Trial Management. With an eye toward holistic care and human psychology, she expanded her studies to include Cognitive Behavioral Therapy. Her diverse training laid the groundwork for a multifaceted approach to clinical neuroscience, bridging biology, diagnostics, and therapeutic psychology.

🧪 Professional Endeavors

Throughout her professional journey, Dr. Santuccione has combined her clinical acumen with entrepreneurial vision. After relocating to Switzerland, she took on advisory roles in several neuro-focused start-ups including Bottneuro, Altoida, Pipra, ReconnectLab, and EqualCare, where she played a pivotal role in aligning scientific discovery with patient-centered innovation. Serving as an Executive Director and Board Member across multiple initiatives, she brought together cross-disciplinary teams to push the frontiers of diagnostics and digital health. Her pro-bono leadership as the Founder and CEO of the Women’s Brain Foundation further demonstrates her commitment to addressing gender disparities in brain health research and care.

🧠 Contributions and Research Focus

Dr. Santuccione’s work focuses on the intersection of neuroscience, gender-specific medicine, and clinical innovation. Her research advocacy highlights the importance of considering sex differences in neurodegenerative diseases such as Alzheimer’s, a field historically underexplored. By promoting personalized approaches to brain health, she has helped shape how researchers and clinicians think about prevention, diagnosis, and treatment across genders. Her insights into cognitive decline, early diagnostic markers, and patient-centric treatment frameworks have influenced both academic thought and clinical practice. Additionally, her work in start-ups integrates AI and data-driven technologies to monitor cognitive health, marking her as a forerunner in digital neuroscience.

🏅 Accolades and Recognition

Dr. Santuccione’s contributions have earned her widespread acclaim both within Switzerland and internationally. She was selected among the Top 100 Business Women in Switzerland from 2018 to 2023, a testament to her sustained influence in science and innovation. In 2019, she was named Woman of the Year by Women in Business CH through a public election, highlighting her societal impact beyond the scientific community. The World Sustainability Award in 2020 and the Bold Women Award Switzerland in 2022 recognized her efforts in building ethical, inclusive scientific models. Most recently, she received the Empowering Women Award 2024 and was featured among the Women to Watch 2025, celebrating her as a role model for future leaders.

🌍 Impact and Influence

Beyond her clinical and scientific achievements, Dr. Santuccione has become a global advocate for change in the healthcare landscape. Her work challenges the traditional silos of medicine, psychology, and technology, offering integrative solutions that are ethical and inclusive. She has empowered countless women in STEM through her foundation, speaking engagements, and mentorship programs. Her influence extends into public policy discussions and public health awareness campaigns, where she brings attention to the need for gender equity and individualized treatment in brain disorders. She is not only a scientist but a communicator who bridges science and society.

💡 Legacy and Future Contributions

Dr. Antonella Chadha Santuccione is a trailblazer shaping the next era of neuroscience through compassion-driven research and visionary leadership. Her legacy lies in her determination to dismantle systemic barriers in medicine—especially those that affect women—and in creating frameworks where innovation serves the individual. With ongoing roles in biotech leadership, nonprofit work, and public advocacy, she is set to further influence global conversations around brain health, mental wellness, and gendered research. Her career is a beacon for aspiring researchers who believe that science should serve humanity with empathy, precision, and equity.

🧬 A Champion for Brain Science and Humanity

Dr. Santuccione embodies the rare synthesis of scientific brilliance, leadership excellence, and humanitarian vision. Her work underscores a commitment to better understanding the human brain—not only through the lens of pathology, but also through the lens of experience, gender, and empathy. As she continues her journey, she stands as a symbol of what it means to be a 21st-century neuroscientist: grounded in evidence, driven by innovation, and devoted to people.

Publication

1. Title: Women’s brain health and brain capital
Authors: Laura Castro-Aldrete, Megan Greenfield, Erin Smith, Harris A. Eyre, Mariapaola Barbato, Lucy Pérez, Antonella Santuccione Chadha
Year: 2025

2. Title: Abortion and Miscarriage on Twitter: Sentiment and Polarity Analysis from a gendered perspective
Authors: Olivier Philippe, María Flores Rodero, Claire Yohalem Furtick, Laura Planas Simón, Maria Teresa Ferretti, Antonella Santuccione Chadha, Laia Subirats Maté, Davide Cirillo, María José Rementeria
Year: 2024

3. Title: Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts
Authors: Matamoros-Angles A, Mohammadi B, Song F, Shafiq M, Brenna S, Puig B, Glatzel M, Altmeppen HC
Year: 2023

4. Title: Global synergistic actions to improve brain health for human development
Authors: Owolabi MO, Leonardi M, Bassetti C, Jaarsma J, Hawrot T, Makanjuola AI, Dhamija RK, Feng W, Straub V, Camaradou J, et al.
Year: 2023

5. Title: Sex and gender considerations in Alzheimer’s disease: The Women’s Brain Project contribution
Authors: Laura Castro-Aldrete, Moser MV, Putignano G, Ferretti MT, Schumacher Dimech A, Antonella Santuccione Chadha
Year: 2023

6. Title: Towards AI-driven longevity research: An overview
Authors: Marino N, Putignano G, Cappilli S, Chersoni E, Antonella Santuccione Chadha, Calabrese G, Bischof E, Vanhaelen Q, Zhavoronkov A, Scarano B
Year: 2023

7. Title: Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
Authors: Pfundstein G, Nikonenko AG, Sytnyk V
Year: 2022

8. Title: Prions induce an early Arc response and a subsequent reduction in mGluR5 in the hippocampus
Authors: Ojeda-Juárez D, Lawrence JA, Soldau K, Pizzo DP, Wheeler E, Aguilar-Calvo P, Khuu H, Chen J, Malik A, Funk G, et al.
Year: 2022

9. Title: Digital biomarkers and sex impacts in Alzheimer’s disease management – potential utility for innovative 3P medicine approach
Authors: Harms RL, Ferrari A, Meier IB, Martinkova J, Santus E, Marino N, Cirillo D, Mellino S, Catuara Solarz S, Tarnanas I, et al.
Year: 2022

🏁 Conclusion

Dr. Antonella Chadha Santuccione’s career is a model of interdisciplinary excellence, innovation, and advocacy. Her ability to blend neuroscience research with executive leadership and public engagement sets her apart as a visionary in brain health. She not only advances the scientific understanding of neurodegeneration but also actively reshapes how gender and equity are addressed in medical research. With a lasting legacy in both scientific and humanitarian domains, she is exceptionally well-suited for high-level recognition such as the Best Researcher Award and remains a powerful voice shaping the future of neuroscience globally.